Top 5 Consumer Stocks That May Implode This Month
As of Feb. 12, 2024, five stocks in the consumer discretionary sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session.
B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the price target from $2.1 to $2.
CommScope shares dipped 6.9% to $2.2150 on Monday.
Manufacturing Company Worthington Beats On Q2, Its Last Quarter As Worthington Industries
Worthington Enterprises Inc (NYSE: WOR), formerly Worthington Industries, Inc., reported a second-quarter FY24 sales decline of 7.5% year-on-year to $1.086 billion, beating the
Worthington Enterprises: Q2 Earnings Insights
Worthington Enterprises (NYSE:WOR) reported its Q2 earnings results on Tuesday, December 19, 2023 at 04:30 PM. Here’s what…
Nasdaq, S&P 500 Futures Bounce Higher As Santa Claus Rally Awaits: Analyst Says December Typically ‘Second-Half Story’
Adding to the positive sentiment is an early Christmas gift from the Bank of Japan, which has maintained its ultra-loose monetary policy.
Earnings Scheduled For December 19, 2023
Companies Reporting Before The Bell
• OrganiGram Holdings (NASDAQ:OGI) is likely to report quarterly loss at $0.10 per share on revenue of $29.52 million.
Earnings Outlook For Worthington Industries
Worthington Industries (NYSE:WOR) is set to give its latest quarterly earnings report on Tuesday, 2023-12-19. Here’s what investors…
Worthington Industries Board of Directors Approved Separation of Worthington Steel
Worthington Industries, Inc. (“Worthington Industries” or the “Company”) (NYSE:WOR), a leading industrial manufacturer, today announced that its Board of Directors (the “Board”)
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.
Drop In Steel Prices Impacts Worthington Industries Q1 Revenue, CEO Anticipates Margin and Demand Improvement
Worthington Industries, Inc. (NYSE: WOR) reported a 15.3% year-over-year decline in